Meyd-873 -

MEYD‑873 delivers potent, durable tumor control in genetically defined models while maintaining a clean safety profile.

Best for: Fans of slow-burn, emotionally driven MILF dramas and admirers of Yuri Honma’s acting. Not for: Viewers seeking wild plots, group scenes, or fast-paced action. MEYD-873

| Feature | Competitor (e.g., sotorasib) | MEYD‑873 | |---------|----------------------------|----------| | | KRAS‑G12C only | KRAS‑G12D + RAF‑dimer inhibition | | Resistance Profile | Frequently re‑activates via BRAF/CRAF dimerization | Dual‑lock blocks that route | | Safety | Grade ≥ 3 liver enzyme elevation in 12 % of pts | No ≥ Grade 3 liver events in pre‑clinical toxicology | | Oral Dosing | BID (twice daily) | QD (once daily) | | Companion Diagnostic | KRAS‑mut status only | KRAS‑G12D + RAF‑DimerScore™ (dual biomarker) | | Feature | Competitor (e